Dana-Farber Cancer Institute shared a post on LinkedIn:
“Matthew S. Davids, has been selected as the next incumbent of the Harold and Virginia Lash Endowed Chair in Lymphoma Research.
Davids, an international leader in chronic lymphocytic leukemia and lymphoma research, has been a member of our faculty since 2011 and was recently appointed Chief of the Division of Lymphoma. The Harold and Virginia Lash Endowed Chair in Lymphoma Research will provide support to help Davids and his team advance innovative research and speed the development of more effective treatments for patients facing lymphoma.
Please join us in congratulating Davids on this well-deserved honor, and in thanking the Lash family for their continued commitment to Dana-Farber.”
Other articles about Dana-Farber Cancer Institute on OncoDaily.